Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX) Financial Statements


Idexx Laboratories Financial Overview

Idexx Laboratories's market cap is currently ―. The company's EPS TTM is $9.425; its P/E ratio is 46.23; Idexx Laboratories is scheduled to report earnings on October 31, 2023, and the estimated EPS forecast is $2.38. See an overview of income statement, balance sheet, and cash flow financials.
Jun 23Mar 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue$ 943.63M$ 900.20M$ 828.57M$ 841.66M$ 860.55M
Gross Profit$ 943.63M$ 542.97M$ 484.93M$ 506.63M$ 514.03M
EBIT$ 296.47M$ 280.40M$ 226.53M$ 245.18M$ 179.40M
EBITDA$ 324.33M$ 308.73M$ 255.25M$ 273.73M$ 207.52M
Net Income Common Stockholders$ 224.24M$ 214.05M$ 172.21M$ 180.94M$ 131.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 132.84M$ 111.37M$ 112.55M$ 99.18M$ 114.36M
Total Assets$ 2.87B$ 2.81B$ 2.75B$ 2.64B$ 2.61B
Total Debt$ 1.13B$ 1.30B$ 1.45B$ 1.51B$ 1.50B
Net Debt$ 1.00B$ 1.19B$ 1.34B$ 1.41B$ 1.38B
Total Liabilities$ 1.78B$ 1.97B$ 2.75B$ 2.16B$ 2.15B
Stockholders Equity$ 1.09B$ 841.10M$ 608.74M$ 476.00M$ 457.01M
Cash Flow-
Free Cash Flow$ 172.84M$ 144.40M$ 124.20M$ 151.31M$ 35.76M
Operating Cash Flow$ 200.31M$ 183.91M$ 173.43M$ 189.00M$ 65.85M
Investing Cash Flow$ -27.47M$ -39.51M$ -49.23M$ -49.20M$ -55.09M
Financing Cash Flow$ -151.03M$ -146.08M$ -116.72M$ -148.83M$ -91.91M
Currency in USD

Idexx Laboratories Earnings and Revenue History

Idexx Laboratories Debt to Assets

Idexx Laboratories Cash Flow

Idexx Laboratories Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis